MALATTIE INFETTIVE

cun id: 
1280

Severe infections and pneumonia in relapsed/ refractory (R/R) patients with chronic lymphocytic leukemia (CLL) treated in the real world with bendamustine and rituximab (BR) chemoimmunotherapy or the kinase inhibitors (KIs) ibrutinib or idelalisib.

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma